<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0585186" disease_type="Disease or Syndrome" abbrv="">Skin hypersensitivity</z:e> to needle puncture (<z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test) together with a positive HLA B5 antigen has been reported as a diagnostic test for <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's syndrome (BS) in Turkish patients </plain></SENT>
<SENT sid="1" pm="."><plain>We have studied the <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test by 2 methods in 7 healthy volunteers who have the HLA B5(Bw 51 split) antigen and 19 patients with BS </plain></SENT>
<SENT sid="2" pm="."><plain>The test was negative in <z:hpo ids='HP_0000001'>all</z:hpo> the <z:mpath ids='MPATH_458'>normal</z:mpath> volunteers and only one of the 19 patients with BS had a positive test by one of the 2 methods </plain></SENT>
<SENT sid="3" pm="."><plain>Cluster analysis of our patients and those reported from Turkey showed no difference in their clinical features </plain></SENT>
<SENT sid="4" pm="."><plain>The positivity of the <z:e sem="disease" ids="C0878631" disease_type="Disease or Syndrome" abbrv="">pathergy</z:e> test, and hence its diagnostic usefulness, seem to differ between Britain and Turkey, and we conclude that this difference is not related to the possession of the HLA B5 (Bw 51 split) antigen </plain></SENT>
</text></document>